Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
39.75
-0.16 (-0.40%)
Dec 20, 2024, 4:00 PM EST - Market closed
Surmodics Employees
Surmodics had 389 employees as of September 30, 2024. The number of employees increased by 13 or 3.46% compared to the previous year.
Employees
389
Change (1Y)
13
Growth (1Y)
3.46%
Revenue / Employee
$324,108
Profits / Employee
-$29,671
Market Cap
569.46M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
GRAIL | 1,360 |
Fulgent Genetics | 1,184 |
SI-BONE | 344 |
Simulations Plus | 247 |
OrthoPediatrics | 247 |
Capricor Therapeutics | 102 |
ORIC Pharmaceuticals | 100 |
CorMedix | 83 |
SRDX News
- 6 weeks ago - Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results - Business Wire
- 7 weeks ago - Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System - Business Wire
- 2 months ago - Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter - Business Wire
- 5 months ago - Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results - Business Wire
- 5 months ago - SURMODICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX - Business Wire
- 6 months ago - Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc. - Business Wire
- 7 months ago - SURMODICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX - Accesswire
- 7 months ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc. - PRNewsWire